Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.

[1]  T. Morita,et al.  Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. , 2004, Psychosomatics.

[2]  T. Morita,et al.  Agitated terminal delirium and association with partial opioid substitution and hydration. , 2003, Journal of palliative medicine.

[3]  P. McNamara.  Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care , 2002, Palliative medicine.

[4]  P. S. Sillevis Smitt,et al.  A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids , 2002, Cancer.

[5]  W. Breitbart,et al.  The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. , 2002, Psychosomatics.

[6]  Augusto Caraceni,et al.  Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. , 2002, Journal of pain and symptom management.

[7]  L. Primavera,et al.  A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl , 2001, Cancer.

[8]  T. Morita,et al.  Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. , 2001, Journal of pain and symptom management.

[9]  L. Primavera,et al.  Intravenous methadone in the management of chronic cancer pain , 2001, Cancer.

[10]  F. Fulfaro,et al.  Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Arakaki,et al.  Clinical utility and validation of the Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient setting. , 2001, General hospital psychiatry.

[12]  W. Breitbart,et al.  An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. , 2000, Oncology.

[13]  E. Bruera,et al.  Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. , 2000, Archives of internal medicine.

[14]  M. Fitch,et al.  Measuring patient outcomes in palliative care: a reliability and validity study of the Support Team Assessment Schedule , 2000, Palliative medicine.

[15]  S. Mercadante.  Opioid rotation for cancer pain , 1999, Cancer.

[16]  S. Mercadante,et al.  Rapid switching from morphine to methadone in cancer patients with poor response to morphine. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  B. Fazekas,et al.  A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. , 1999, Journal of pain and symptom management.

[18]  E. Bruera,et al.  The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain , 1999, Supportive Care in Cancer.

[19]  T. Morita,et al.  The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients , 1999, Supportive Care in Cancer.

[20]  M. Ashby,et al.  Opioid substitution to reduce adverse effects in cancer pain management , 1999, The Medical journal of Australia.

[21]  E. Bruera,et al.  Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. , 1998, Journal of pain and symptom management.

[22]  S. Mercadante.  Opioid rotation in cancer pain , 1998 .

[23]  S. Ahmedzai,et al.  Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life , 1997 .

[24]  E. Bruera,et al.  The frequency and clinical course of cognitive impairment in patients with terminal cancer , 1997 .

[25]  D. Parker,et al.  Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. , 1996, Journal of pain and symptom management.

[26]  J. Lees,et al.  Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management , 1995, PAIN®.

[27]  M. Falardeau,et al.  [Palliative care unit]. , 1979, L'union medicale du Canada.